Importantly, we found that HER2-CXCR5-CCR6-CAR T cells, in addition to demonstrating migration, homing, and anti-tumor effects, also exhibited significant expansion and survival advantages, as confirmed by both in vitro and in vivo experiments. This evidence concerns the gene CCR6 and neoplasm.